chr8-140658761-A-T

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The ENST00000519993.5(PTK2):​n.*3544T>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.411 in 221,350 control chromosomes in the GnomAD database, including 20,514 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.39 ( 12839 hom., cov: 32)
Exomes 𝑓: 0.46 ( 7675 hom. )

Consequence

PTK2
ENST00000519993.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.831

Publications

29 publications found
Variant links:
Genes affected
PTK2 (HGNC:9611): (protein tyrosine kinase 2) This gene encodes a cytoplasmic protein tyrosine kinase which is found concentrated in the focal adhesions that form between cells growing in the presence of extracellular matrix constituents. The encoded protein is a member of the FAK subfamily of protein tyrosine kinases but lacks significant sequence similarity to kinases from other subfamilies. Activation of this gene may be an important early step in cell growth and intracellular signal transduction pathways triggered in response to certain neural peptides or to cell interactions with the extracellular matrix. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 8-140658761-A-T is Benign according to our data. Variant chr8-140658761-A-T is described in ClinVar as Benign. ClinVar VariationId is 1226102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.488 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PTK2NM_001352702.2 linkc.*705T>A 3_prime_UTR_variant Exon 36 of 36 ENST00000696786.1 NP_001339631.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PTK2ENST00000696786.1 linkc.*705T>A 3_prime_UTR_variant Exon 36 of 36 NM_001352702.2 ENSP00000512868.1

Frequencies

GnomAD3 genomes
AF:
0.389
AC:
59043
AN:
151950
Hom.:
12828
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.181
Gnomad AMI
AF:
0.570
Gnomad AMR
AF:
0.393
Gnomad ASJ
AF:
0.541
Gnomad EAS
AF:
0.366
Gnomad SAS
AF:
0.431
Gnomad FIN
AF:
0.437
Gnomad MID
AF:
0.446
Gnomad NFE
AF:
0.493
Gnomad OTH
AF:
0.451
GnomAD4 exome
AF:
0.460
AC:
31872
AN:
69282
Hom.:
7675
Cov.:
0
AF XY:
0.469
AC XY:
15027
AN XY:
32052
show subpopulations
African (AFR)
AF:
0.182
AC:
593
AN:
3254
American (AMR)
AF:
0.423
AC:
892
AN:
2108
Ashkenazi Jewish (ASJ)
AF:
0.531
AC:
2316
AN:
4362
East Asian (EAS)
AF:
0.353
AC:
3507
AN:
9942
South Asian (SAS)
AF:
0.390
AC:
234
AN:
600
European-Finnish (FIN)
AF:
0.424
AC:
162
AN:
382
Middle Eastern (MID)
AF:
0.510
AC:
213
AN:
418
European-Non Finnish (NFE)
AF:
0.501
AC:
21292
AN:
42474
Other (OTH)
AF:
0.464
AC:
2663
AN:
5742
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
822
1645
2467
3290
4112
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.388
AC:
59065
AN:
152068
Hom.:
12839
Cov.:
32
AF XY:
0.388
AC XY:
28812
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.181
AC:
7518
AN:
41512
American (AMR)
AF:
0.392
AC:
5980
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.541
AC:
1877
AN:
3472
East Asian (EAS)
AF:
0.367
AC:
1899
AN:
5180
South Asian (SAS)
AF:
0.433
AC:
2084
AN:
4814
European-Finnish (FIN)
AF:
0.437
AC:
4615
AN:
10550
Middle Eastern (MID)
AF:
0.446
AC:
131
AN:
294
European-Non Finnish (NFE)
AF:
0.493
AC:
33477
AN:
67962
Other (OTH)
AF:
0.457
AC:
964
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1752
3505
5257
7010
8762
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
560
1120
1680
2240
2800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.302
Hom.:
880
Bravo
AF:
0.379
Asia WGS
AF:
0.392
AC:
1367
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 18, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 24930376)

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.44
CADD
Benign
6.8
DANN
Benign
0.80
PhyloP100
0.83
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7460; hg19: chr8-141668860; API